Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Soligenix
SNGX
$5.59M
| $178K | ﹤0.01% |
811
+55
| +7% | +$12.4K |
|
3227
Cemtrex
CETX
$4.17M
| – | – |
0
| – | – |
|
|
EMX
3228
DELISTED
EMX Royalty
EMX
| $175K | ﹤0.01% |
149,200
+45,458
| +44% | +$53.7K |
|
3229
United Natural Foods
UNFI
$3.07B
| $173K | ﹤0.01% |
13,100
-848,650
| -98% | -$11.5M |
|
|
MAMS
3230
DELISTED
MAM Software Group Inc. New
MAMS
| $172K | ﹤0.01% |
20,200
-3,505
| -15% | -$29.1K |
|
|
JMP
3231
DELISTED
JMP Group LLC
JMP
| $171K | ﹤0.01% |
45,633
+17,800
| +64% | +$75.9K |
|
|
AHPI
3232
DELISTED
Allied Healthcare Products
AHPI
| $168K | ﹤0.01% |
92,140
+2,000
| +2% | +$3.73K |
|
|
SDRL
3233
DELISTED
Seadrill Limited Common Stock
SDRL
| $168K | ﹤0.01% |
20,253
-156,019
| -89% | -$1.41M |
|
3234
Danaos Corp
DAC
$2.57B
| $167K | ﹤0.01% |
13,493
+154
| +1% | +$1.95K |
|
3235
Key Tronic
KTCC
$41.9M
| $167K | ﹤0.01% |
27,000
+8,500
| +46% | +$54.6K |
|
3236
Comstock Holding Companies
CHCI
$151M
| $165K | ﹤0.01% |
75,884
+5,200
| +7% | +$11.5K |
|
3237
Rockwell Medical
RMTI
$28.6M
| $165K | ﹤0.01% |
+264
| New | +$120K |
|
|
ARTX
3238
DELISTED
Arotech Corporation
ARTX
| $160K | ﹤0.01% |
54,700
+24,300
| +80% | +$77.6K |
|
3239
SITE Centers
SITC
$224M
| $159K | ﹤0.01% |
+14,996
| New | +$152K |
|
3240
SiNtx Technologies
SINT
$9.73M
| $158K | ﹤0.01% |
1
| – | – |
|
|
RRTS
3241
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $158K | ﹤0.01% |
+15,071
| New | +$184K |
|
3242
Fulgent Genetics
FLGT
$469M
| $155K | ﹤0.01% |
+26,100
| New | +$120K |
|
3243
Prothena Corp
PRTA
$422M
| $155K | ﹤0.01% |
+12,800
| New | +$160K |
|
3244
Traws Pharma
TRAW
$6.55M
| $154K | ﹤0.01% |
125
-1
| -0.8% | -$1.19K |
|
|
CCRN
3245
DELISTED
Cross Country Healthcare
CCRN
| $153K | ﹤0.01% |
21,800
+8,000
| +58% | +$68.6K |
|
|
LFT
3246
Lument Finance Trust
LFT
$36.1M
| $153K | ﹤0.01% |
+43,934
| New | +$149K |
|
3247
Fennec Pharmaceuticals
FENC
$330M
| $151K | ﹤0.01% |
+31,100
| New | +$204K |
|
|
BDRX
3248
Biodexa Pharmaceuticals
BDRX
$1.34M
| – | – |
0
| – | – |
|
3249
Denison Mines
DNN
$2.55B
| $150K | ﹤0.01% |
289,000
+37,100
| +15% | +$19.2K |
|
|
ROYT
3250
DELISTED
PACIFIC COAST OIL TRUST
ROYT
| $150K | ﹤0.01% |
70,200
+2,000
| +3% | +$3.83K |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.